Objective To understand how the lives of people with Crohn's disease (CD) are affected. Most research in CD has focused on symptoms and functioning rather than on how these outcomes influence quality of life (QoL).
Design As part of a study to develop a CD-specific patient-reported outcome measure, qualitative interviews were conducted with patients from Manchester Royal Infirmary to determine how CD affects QoL. The needs-based model was adopted for the study. The interviews, which took the form of focused conversations covering all aspects of the impact of CD and its treatment, were audio-recorded. Theoretical thematic analysis of the transcripts identified needs affected by CD.
Results Thirty patients (60% female) aged 25–68 years were interviewed. Participants had experienced CD for between 2 and 40 years. Nearly 1300 statements relating to the impact of CD were identified. Thirteen main need themes were identified: nutrition, hygiene, continence, freedom from infection, security, self-esteem, role, attractiveness, relationships, intimacy, clear-mindedness, pleasure and autonomy.
Conclusions The findings from the interviews indicate that CD has a major impact on need-fulfilment. Such issues should be addressed in CD audit, clinical trials and when evaluating clinical practice.
- CROHN'S DISEASE
- QUALITY OF LIFE
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Contributors JW, SPM and JT were involved with the conception and design of the study, acquisition of data, interpretation of data and writing of the manuscript. KK was involved in the recruitment of participants, interpretation of data, and contributed to and reviewed the manuscript. All authors read and approved the final manuscript.
Funding Crohn's and Colitis UK part-funded the study.
Competing interests KK has received fees for consultancy work from Abbvie, MSD, Takeda, Actavis, Dr Faulk and Vifor.
Ethics approval National Research Ethics Service Committee North West.
Provenance and peer review Not commissioned; externally peer reviewed.